TCV Trust & Wealth Management’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$311K Sell
3,604
-358
-9% -$29.8K 0.02% 176
2026
Q2
$267K Sell
3,962
-303
-7% -$20.2K 0.02% 189
2026
Q1
$268K Sell
4,265
-148
-3% -$10.3K 0.02% 188
2025
Q4
$293K Sell
4,413
-238
-5% -$15.4K 0.02% 185
2025
Q3
$313K Sell
4,651
-319
-6% -$25.2K 0.03% 183
2025
Q2
$434K Buy
+4,970
New +$390K 0.04% 156

Other funds holding DXCM

TCV Trust & Wealth Management's DXCM Position: Q3 2026 in Review

TCV Trust & Wealth Management reduced its DexCom (DXCM) stake by 9% in Q3 2026, selling an estimated $29.8K and leaving 3,604 shares worth $311K. The position accounts for 0.02% of the portfolio, ranked #176.

TCV Trust & Wealth Management first reported a position in DXCM in Q2 2025 and has held it in 6 quarters since. The position peaked at $434K in Q2 2025. 1,056 funds tracked by Wall St. Rank hold DXCM as of Q3 2026.

  • TCV Trust & Wealth Management held 3,604 shares of DexCom worth $311K as of Q3 2026.
  • TCV Trust & Wealth Management sold 358 DexCom shares in Q3 2026, an estimated $29.8K.
  • DexCom made up 0.02% of TCV Trust & Wealth Management's portfolio in Q3 2026, its #176 holding.
  • TCV Trust & Wealth Management first reported a position in DexCom in Q2 2025 and has held it in 6 quarters since.
  • TCV Trust & Wealth Management's DexCom position peaked at $434K in Q2 2025.
  • 1,056 funds tracked by Wall St. Rank held DexCom as of Q3 2026.

Based on TCV Trust & Wealth Management's 13F filing for Q3 2026, filed 16 Oct 2026.